Arsenic trioxide concentration determines the fate of Ewing’s sarcoma family tumors and neuroblastoma cells in vitro  by Jung, Hyun Sook et al.
FEBS Letters 580 (2006) 4969–4975Arsenic trioxide concentration determines the fate of Ewing’s
sarcoma family tumors and neuroblastoma cells in vitro
Hyun Sook Junga,1, Han-Seong Kimb,1, Min-Jae Leec, Hee Young Shind, Hyo Seop Ahnd,
Kyung-Ha Ryue, Ju-Young Seohf, Chong Jai Kima, Ja June Janga,*
a Department of Pathology, Seoul National University College of Medicine, 28 Yongon-dong, Jongno-gu, 110-799 Seoul, Korea
b Department of Pathology, Inje University Ilsan Paik Hospital, Koyang, Korea
c Department of Veterinary Lab Animal Medicine & Science, Kangwon National University, Chuncheon, Korea
d Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
e Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Korea
f Department of Microbiology, Ewha Womans University College of Medicine, Seoul, Korea
Received 3 May 2006; revised 25 July 2006; accepted 26 July 2006
Available online 8 August 2006
Edited by Vladimir SkulachevAbstract Arsenic trioxide (As2O3) induces both the diﬀerentia-
tion and apoptosis of acute promyelocytic leukemia cells in a
concentration dependent manner. We assessed the eﬀects of
As2O3 in CADO-ES Ewing’s sarcoma (ES), JK-GMS periphe-
ral primitive neuroectodermal tumor (PNET), and SH-SY5Y
neuroblastoma cells, as they share common histogenetic back-
grounds. As2O3 at low concentrations (0.1–1 lM) induced SH-
SY5Y diﬀerentiation, and whereas PNET cells acquired a
slightly diﬀerentiated phenotype, change was minimal in ES
cells. Extracellular signal-regulated kinase 2 (ERK2) was acti-
vated at low As2O3 concentrations, and PD98059, an inhibitor
of MEK-1, blocked SH-SY5Y cell diﬀerentiation by As2O3.
High concentrations (2–10 lM) of As2O3 induced the apoptosis
in all three cell lines, and this was accompanied by the activation
of c-jun N-terminal kinase. The generation of H2O2 and activa-
tion of caspase 3 were identiﬁed as critical components of As2O3-
induced apoptosis in all of the above cell lines. Fibroblast growth
factor 2 enhanced As2O3-induced apoptosis in JK-GMS cells.
The overall eﬀects of As2O3 strongly suggest that it has thera-
peutic potential for the treatment of ES/PNET.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Arsenic trioxide (As2O3) is toxic to various human cancers
[1–5], and has been primarily used in the treatment of acute
promyelocytic leukemia (APL). Moreover, its therapeuticAbbreviations: As2O3, arsenic trioxide; APL, acute promyelocytic
leukemia; NB, neuroblastoma; ES, Ewing’s sarcoma; PNET, periph-
eral primitive neuroectodermal tumor; MAPKs, mitogen activated
protein kinases; ERK1/2, extracellular signal-regulated kinase 1/2;
JNK, c-jun N-terminal kinase; FGF2, ﬁbroblast growth factor 2; ROS,
reactive oxygen species
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Arsenic compounds at low doses (0.1–1 lM) induce APL cell
diﬀerentiation by degrading promyelocytic leukemia protein
(PML)-retinoic acid receptor a (RARa) fusion protein, which
is speciﬁc for APL cells with the chromosomal translocation
t(15;17), whereas cells treated with 1–2 lM As2O3 undergo
apoptosis by both PML-RARa-dependent and -independent
mechanisms. Moreover, the downregulation of bcl-2 and the
activation of caspase 3 are associated with As2O3-induced
APL cell apoptosis [4–7], and ascorbic acid is known to en-
hance the eﬀect of As2O3 in vivo [8].
Neuroblastoma (NB) is one of the most common extracra-
nial solid tumors of childhood, and shares some similarity with
APL in that some of the tumors are responsive to retinoic acid
(RA). Moreover, As2O3 induces the apoptosis of various NB
cell lines by reducing the level of intracellular GSH (glutathi-
one) and by activating caspase 3 [1,9,10]. Ewing’s sarcoma
(ES) and peripheral primitive neuroectodermal tumor (PNET)
are small round-cell tumors that predominantly aﬀect bone
and soft tissues in children and adolescents. Despite the devel-
opments of therapeutic modalities, ES/PNET patients with ad-
vanced disease have a poor prognosis as compared with those
with other solid tumors of childhood. Although the histogen-
esis of ES/PNET remains debatable, the current consensus is
that they are derived from neural crest and have primitive neu-
ral characteristics.
As2O3 at high doses induces the apoptosis of NB cells, and
this is accompanied by the activation of caspase 3. Moreover,
sensitivity to As2O3 is inversely proportional to the intracellular
level of reduced GSH [9]. Although ES/PNET cells have
features in common with NB cells, the eﬀects of As2O3 have
not been investigated in these cells. Therefore, in the present
study, we compared the eﬀects of As2O3 in ES/PNET and NB
cells. High and low concentrations of As2O3 were found to dif-
ferentially modulate the fates of these cells, i.e. they induced dif-
ferentiation and apoptosis, respectively, as is the case for APL
cells. Extracellular signal-regulated kinase 2 (ERK2) activation
by low dose As2O3 was found to be linked with the diﬀerentia-
tion of SH-SY5Y cells, whereas reactive oxygen species (ROS)
generation by high dose As2O3 induced apoptosis in all
cell lines. As2O3 appears to have potential as a treatment for
ES/PNET and NB by inducing either the diﬀerentiation or
apoptosis of cells.blished by Elsevier B.V. All rights reserved.
Fig. 1. The growth inhibitory eﬀect of As2O3. ES/PNET and NB were
treated with the indicated concentrations of As2O3. After 3 days, cell
viabilities were determined by MTT assay. Exposure of these cells to
As2O3 led to concentration-dependent decreases in cell viabilities.
Results are presented as the means ± S.D. of percentages of treated
versus non-treated cells (n = 3).
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2.1. Cell lines and culture methods
ES (CADO-ES)/PNET (JK-GMS) and NB (SH-SY5Y) cell lines
were used in the study. Cells were grown in RPMI 1640 supplemented
with 10% fetal bovine serum and antibiotics, at 37 C in a humidiﬁed
5% CO2/95% air atmosphere. As2O3 was dissolved in 1 N NaOH, then
diluted to 1 mM with phosphate-buﬀered saline (PBS), and this was
used as stock solution. PD98059 (Cell Signaling Technology, Beverly,
MA), an inhibitor of MEK-1, and SP600125 [anthra(1,9-cd)pyrazol-
6(2H)-one; 1,9-pyrazoloanthrone] (Calbiochem, La Jolla, CA, USA),
a c-jun N-terminal kinase (JNK) speciﬁc inhibitor, were used. The con-
centration of antioxidant NAC (N-acetylcysteine) was 5 or 10 mM.
Broad caspase inhibitor z-VAD-fmk (ﬂuoromethyl ketone) was
obtained from R&D systems (Minneapolis, MN) and used at a ﬁnal
concentration of 20 lM. Fibroblast growth factor 2 (FGF2) purchased
from Sigma was dissolved in sterile PBS and treated at concentrations
of 50 or 100 ng/mL.
2.2. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] assay
Cells were treated with various concentrations of As2O3 were grown,
and MTT (500 lg/mL) was added after As2O3 treatment for 24, 48 or
72 h. After incubation for 3 h with MTT, absorbance was measured at
490 nm using an ELISA microplate reader.
2.3. Immunoblotting
Cell lysates were prepared using RIPA buﬀer [50 mM Tris–HCl (pH
7.4), 150 mMNaCl, 1% Triton X-100, 0.1% SDS, 2 mM EDTA, 2 mM
PMSF and protease inhibitors]. Extracts were electrophoresed in 10%
SDS–polyacrylamide gel and electrotransferred to nitrocellulose mem-
branes. Membranes were then blocked with TBST (tris-buﬀered saline
supplemented with 1% Tween-20) containing 3% non-fat skim milk at
room temperature for 1 h. The membranes were then incubated with
anti-neuroﬁlament (Zymed, San Francisco, CA), anti-phospho-JNK
(Cell Signaling Technology, Beverly, MA), anti-JNK (Cell Signaling
Technology), anti-phospho-ERK1/2 (Cell Signaling Technology),
anti-ERK1/2 (Cell Signaling Technology), anti-caspase 3 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and anti-actin (Santa Cruz Bio-
technology) antibodies at 4 C overnight. After incubation with HRP-
conjugated secondary antibody (Amersham, Piscataway, NJ), signals
were detected with ECL (enhanced chemiluminescence).
2.4. H2O2 production
Cells were treated with 10 mMNAC an hour prior to treatment with
5 lM As2O3. After 6 h of As2O3 treatment, cells were labeled with
20 lM of 2 0,7 0-DCFH-DA (dichloroﬂuorescein diacetate; Sigma–
Aldrich Co., St. Louis, MO) for 30 min at 37 C. After washing with
PBS, DCF ﬂuorescence (an ROS oxidized form of DCFH-DA) was
measured using ﬂuorescence microscopy with excitation and emission
settings of 495 and 525 nm, respectively.
2.5. Annexin V-FITC/PI staining
After cells had been treated with As2O3for 24 h, apoptotic rates were
analyzed by ﬂow cytometry using Annexin V-FITC/PI kits (MBL;
Medical & Biological Laboratories, Nagoya, Japan). Cells were con-
sidered as apoptotic, necrotic, or viable if they showed Annexin
V+PI, PI+, or no staining, respectively. Samples were prepared
according to the manufacturer’s instructions and analyzed using a Bec-
ton Dickinson FACS Calibur ﬂow cytometer.
2.6. DNA gel electrophoresis
Cells were collected by centrifugation at 2000 · g for 5 min, washed
twice with ice-cold PBS, resuspended in lysis buﬀer [10 mM Tris–HCl
(pH 7.4), 100 mM NaCl, 25 mM EDTA, 0.5% SDS, and 0.3 mg/mL
proteinase K], and incubated at 48 C overnight. Cold 5 M NaCl solu-
tion was then added to a ﬁnal concentration of 1 M, and mixtures were
vortexed and centrifuged at 14000 · g for 5 min. After precipitation
with isopropanol, cell pellets were resuspended in TE buﬀer [10 mM
Tris–HCl (pH 7.4), 1 mM EDTA] containing 20 lg/mL DNase free
RNase and then incubated at 37 C for 1 h. DNA samples (20 lg) were
subjected to electrophoresis in 1% agarose gels, and visualized by ethi-
dium bromide staining.2.7. Measurement of intracellular GSH
Intracellular GSH contents were measured using a Glutathione
Assay Kit (Calbiochem). Cells were homogenized in 5% metaphospho-
ric acid and then separated by centrifugation at 6000 · g. Supernatants
were used to measure GSH contents, according to the manufacturer’s
instructions. Pellets were dissolved in RIPA lysis buﬀer and analyzed
for protein concentrations using the BCA method. GSH content
normalized versus untreated controls.
2.8. Caspase 3 activity
Cells were treated with 5 lM As2O3 for 16 h in the presence or ab-
sence of z-VAD-fmk, SP600125, or NAC, and then resuspended in
RIPA buﬀer. After centrifugation at 14000 · g for 20 min, superna-
tants were collected. Assays were performed in 96-well plates by incu-
bating 25 lg of cell lysates in 100 lL of reaction buﬀer [1% NP-40,
20 mM Tris–HCl (pH 7.4), 137 mM NaCl, 10% glycerol] containing
caspase 3 substrate (Ac-DEVD-pNA; Ac-Asp-Glu-Val-Asp-pNA) at
5 lM. Lysates were incubated at 37 C for 2 h. Absorbances were mea-
sured at 405 nm using an ELISA microplate reader.
2.9. Statistical analysis
Data are expressed as means ± standard error of mean (S.E.M.).
Diﬀerent treatments were compared using the Mann–Whitney U test.
Statistical analyses were performed using SPSS 11.5 software. For all
analyses, P < 0.05 was considered statistically signiﬁcant. All experi-
ments were performed at least three times.3. Results
3.1. Growth inhibitory eﬀect of As2O3 on the ES/PNET and NB
cell lines
CADO-ES, JK-GMS, and SH-SY5Y cells were found to be
sensitive to increasing concentrations (0.5–10 lM) of As2O3
over 72 h by MTT assays (Fig. 1). The low (0.5–1 lM) and
high (P 2 lM) levels of As2O3 used were based on the ﬁndings
of previous studies [1,11,12]. Treatment of cells with As2O3 at
2, 5, or 10 lM led to a dose-dependent decrease in cell viability
for all cell lines. At 2 lM As2O3, the viable cell number reduc-
tions were more prominent in JK-GMS cells than in CADO-
ES or SH-SY5Y cells. The cell viabilities of JK-GMS and
CADO-ES/SH-SY5Y cells were 30% and 70%, respectively.
However, at 10 lM As2O3 signiﬁcant diﬀerence was not noted
between the viabilities of SH-SY5Y cells and CADO-ES/JK-
GMS cells (20% and 10%, respectively).
Fig. 2. Neuronal diﬀerentiation by low dose As2O3. (A) Treatment with 0.2 or 0.5 lM As2O3 for 3 days induced neuronal diﬀerentiation
characterized by neurite extension, especially in SH-SY5Y cells. (B) Immunoblot for neuroﬁlament and phospho-ERK1/2 in SH-SY5Y and CADO-
ES cell lines at the indicated doses. Cellular proteins were resolved in 6–10% SDS–polyacrylamide gels. Membranes were probed with anti-
neuroﬁlament, phospho-ERK1/2 and ERK1/2 primary antibodies. (C) SH-SY5Y cells were treated with 0.2 lM As2O3 alone or combination with
50 lM PD98059 for 3 days and then immunoblotted. ERK2 activation by low dose As2O3 induced NB cells diﬀerentiation. However, PNET and ES
cells showed hardly any neurite extension changes or ERK1/2 activation. Results are presented as relative fold activations versus control levels and
are expressed as means ± S.D. (n = 3).
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To investigate whether As2O3 at low concentrations induces
diﬀerentiation, we assessed the expression of neuroﬁlament
and also investigated the relationship between diﬀerentiation
and mitogen activated protein kinase (MAPK) pathways
(Fig. 2). Treatment of cells with 0.2 or 0.5 lM As2O3 induced
the neuronal diﬀerentiations of SH-SY5Y cells, as character-
ized by neurite extension. JK-GMS cells also showed neurite
extension, but to a lesser extent than SH-SY5Y cells, whereas
CADO-ES cells did not show distinct morphological changes
(Fig. 2A). Neuronal diﬀerentiation was accompanied by the in-
creased expression of 160 kDa neuroﬁlament and the phospho-
rylations of p42, rather than p44, in SH-SY5Y cells. Although
both p44 and p42 are readily detectable in JK-GMS PNET or
CADO-ES cells, these changes were not as prominent as in
SH-SY5Y cells. The ERK1/2 (p44/42) antibody used in our
experiments detected diﬀerential phosphorylation patterns of
p44/42 in CADO-ES and SH-SY5Y cells suggesting that the
diﬀerence of them is cell type speciﬁc (Fig. 2B).
As As2O3-induced neuronal diﬀerentiation was accompanied
by p42 phosphorylation, we tested whether ERK1/2 inhibition
blocked this diﬀerentiation. Pre-treatment of cells with 50 lM
PD98059, a speciﬁc inhibitor of MEK-1, blocked both the
phosphorylation of p42 and the neuronal diﬀerentiation in-
duced by 0.2 lM As2O3, demonstrating that p42 activation is
critically required for neuronal diﬀerentiation (Fig. 2C).3.3. Biological eﬀects of As2O3 at high concentrations
Analyses of MAPK phosphorylation showed that JNK was
activated in ES/PNET and NB cells treated with high concen-
trations of As2O3 (5 or 10 lM). Moreover, pretreatment with
SP600125, a speciﬁc JNK inhibitor, one hour prior to As2O3
treatment, abrogated JNK phosphorylation, but total JNK
levels were unaﬀected (Fig. 3A and B).
Because As2O3 is known to generate ROS in tumor cell lines
[11,13,14]. We assessed H2O2production using the cell perme-
able oxidation-dependent ﬂuorescence dye 2 0,7 0-DCFH-DA.
It was found that the intensity of the mean oxidized DCF peak
was increased by 3- and 2.7-fold compared to controls after 6 h
of As2O3 treatment in CADO-ES and JK-GMS cells, respec-
tively. Moreover, H2O2 generation was found to be associated
with increased apoptosis by As2O3, which was markedly sup-
pressed by pre-treatment with 10 mM NAC, a ROS inhibitor,
an hour prior to As2O3 treatment (Fig. 3C). In addition, and
analysis of intracellular GSH contents showed that treatment
with 5 lM As2O3 for 8 h reduced GSH contents and that
10 lM SP600125 augmented this decrease. However, intracel-
lular GSH contents were signiﬁcantly restored by 10 mM
NAC (Fig. 3D).
We further assessed the signiﬁcance of JNK activation and
H2O2 generation on the biological eﬀects of As2O3. ES/PNET
and NB cells were cultured with 5 lM As2O3 for 24 h in the
presence of SP600125 or NAC, and cellular viabilities and
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Fig. 4. Eﬀects of FGF2 on As2O3-induced apoptosis in the JK-GMS cell line. (A) Cells were treated with multiple combinations of concentrations of
As2O3 and FGF2. After 2 days of combined FGF2 + As2O3 treatment increased numbers of dead and ﬂoating cells were observed. Cell viabilities
were determined using MTT assays. Results are shown as means ± S.D. (n = 3). (B) JK-GMS cells were treated with As2O3 alone or in combination
with 50 ng/mL FGF2. Cell death types were determined by double staining with Annexin V-FITC and PI. FGF2 + As2O3 treatment was found to be
more eﬀective at causing apoptosis than As2O3 or FGF2 alone.
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shown) and ﬂow cytometry after Annexin V-FITC/PI staining.
Pre-treatment with 10 lM SP600125 enhanced As2O3-induced
growth inhibition and apoptosis, and 10 mM NAC eﬀectively
blocked the eﬀects of As2O3 on cell growth and apoptosis.
However, SP600125 or NAC alone did not aﬀect cell growth
or apoptosis. Flow cytometric analysis showed that 5 lM
As2O3 resulted in a 2-fold increase in the apoptosis compared
to control cells in all three cell lines (Fig. 3E). Moreover, the
eﬀects of SP600125 and NAC on the nucleosomal DNA frag-Fig. 3. Biological eﬀects due to high dose As2O3. (A) JK-GMS cells were trea
polyacrylamide gels. Membranes were probed with anti-phospho-JNK and
As2O3 alone or combination with 10 or 20 lM SP600125 for 8 h and t
phosphorylation, which was eﬃciently blocked by SP600125. Results are pr
levels (n = 3). (C) Increased generation of H2O2 following As2O3 treatmen
combination with 10 mM NAC for 6 h. The cells were then labeled with 20 lM
this was markedly suppressed by pre-treatment with 10 mM NAC. The graph
intracellular GSH content. ES/PNET and NB cells were treated with As2
Glutathione Assay Kit, as described in Section 2. As2O3-induced H2O2 gen
contents. GSH contents are represented relative to untreated controls. Measu
staining with Annexin V-FITC/PI. The cells were treated with the indicated c
the means ± S.D. of fold activations versus controls (n = 3). As2O3 treatm
fragmentation caused by treating cells with the indicated doses of vari
electrophoresed in 1% agarose gels. (G) Relationship between ROS generatio
alone or combined with 10 mM NAC for 16 h. Cellular proteins were resolve
ProCPP32 and actin primary antibodies. (H) Cells were treated with 5 lM A
were prepared and incubated for 2 h at 37 C with Ac-DEVD-pNA, and then
to induce a caspase dependent mode of apoptosis. Activities are presented a
bmentation associated with As2O3-induced apoptosis were also
consistent with the results of MTT assay and ﬂow cytometry.
Treatment with 10 lM SP600125 was associated with more
distinct DNA oligonucleosomal ladders than treatment with
As2O3, whereas 10 mM NAC almost completely abrogated
DNA ladder formation (Fig. 3F).
We assessed whether ROS generation is related with the acti-
vations of JNK and caspase 3. Treatment of the ES/PNET
and NB cells with 5 lM As2O3 for 8 or 16 h induced JNK
phosphorylation (data not shown) and caspase 3 activation,ted at the indicated doses. Cellular proteins were resolved in 10% SDS–
JNK primary antibodies. (B) CADO-ES cells were treated with 5 lM
hen immunoblotted. Higher concentrations of As2O3 induced JNK
esented as the means ± S.D. of relative fold activations versus control
t in ES/PNET cells. Cells were treated with 5 lM As2O3 alone or in
DCFH-DA. H2O2 generation was increased by As2O3 treatment, and
s represent changes in relative ﬂuorescence intensities. (D) Changes in
O3 for 8 h, and intracellular GSH contents were measured using a
eration was found to be inversely correlated with intracellular GSH
rements of As2O3-induced apoptosis. (E) Flow cytometric analysis by
oncentrations of As2O3, SP600125 and NAC. Results are presented as
ent induced the apoptosis of ES/PNET and NB cell lines. (F) DNA
ous reagents for 24 h in JK-GMS. Extracted genomic DNA was
n and the activation of caspase 3. Cells were treated with 5 lM As2O3
d in 10% SDS–polyacrylamide gels. Membranes were probed with anti-
s2O3 alone or in combination with these reagents for 8 h. Cell extracts
DEVDase activity was determined colorimetrically. As2O3 was found
s fold increases of values treated versus non-treated controls.
4974 H.S. Jung et al. / FEBS Letters 580 (2006) 4969–4975respectively, and these were completely blocked by 10 mM
NAC pretreatment an hour prior to As2O3 treatment
(Fig. 3G). Caspase activities after treating the cells with
As2O3 alone or with As2O3 in the presence of z-VAD-fmk,
NAC or SP600125 were also examined. When JK-GMS cells
were incubated for 16 h with 5 lM As2O3, a 2-fold increase
in caspase activity was observed compared to untreated cells,
but caspase activities remained at the control level with
As2O3 was treated in the presence of z-VAD-fmk or NAC.
Moreover, the combination As2O3 and SP600125 markedly en-
hanced caspase activity versus As2O3 alone, demonstrating
that the apoptosis is caspase 3 dependent (Fig. 3H).3.4. Eﬀects of FGF2 on As2O3-induced apoptosis
ES/PNET cells undergo apoptosis when treated with FGF2
in a dose-dependent manner [15], and therefore, we investi-
gated the eﬀect of FGF2 in the presence of As2O3 (Fig. 4).
JK-GMS cells were treated with 2 or 3 lM As2O3, 50 or
100 ng/mL of FGF2, or a combination of FGF2 and As2O3.
After 2 days of exposure to As2O3, and FGF2, increases in
growth inhibition and apoptosis by MTT assay (Fig. 4A)
and Annexin V-FITC/PI staining (Fig. 4B) were observed ver-
sus cell treated with As2O3 or FGF2 alone, and this occurred
in a dose dependent manner. Moreover, the decrease in cell
viability observed at 48 h after treatment with As2O3 and
FGF2 was much more profound than that caused by either
of the reagents alone. Taken together, it is thought that the
treatment of As2O3 and FGF2 combination induces the syner-
gistic eﬀect in JK-GMS cells.4. Discussion
We investigated the eﬀects of As2O3 at diﬀerent concentra-
tions on ES/PNET cell lines and compared these with its
eﬀects in the NB cell line. Whereas NB cells clearly showed
morphological and biological characteristics of neuronal dif-
ferentiation by As2O3, these changes were minimal or absent
in similarly treated PNET and ES cells. Moreover, As2O3 at
low concentrations inhibited cellular growth and induced the
neuronal diﬀerentiation of SH-SY5Y NB cells. This ﬁnding
is in contrast with the results in a previous study [10], and
may be due to diﬀerences in the NB cell lines used in terms
of their abilities to diﬀerentiate. As compared with NB cells,
ES/PNET cells have rather primitive neuronal characteristics
in vivo and in vitro, yet PNET cells have more diﬀerentiated
phenotypes than ES cells. The extent of neuronal diﬀerentia-
tion induced by As2O3 appears to be related to the intrinsic
potential of the cells to diﬀerentiate.
Mitogen activated protein kinases (MAPKs) include ERK1/
2, JNK and p38, and are family of serine/threonine kinases
that participate in signaling pathways activated by various
external stimuli [11,12,16–18], and of these ERK1/2 is an
important component of As2O3-induced neuronal diﬀerentia-
tion. MAPKs are also involved in the As2O3-induced cell
deaths of other cell types, such as, prostate cancer cells and
HeLa cells [16,19–21], and these are known to occur via the
downregulation of bcl-2 [11,12,18,22]. Thus, we tested whether
the phosphorylation of JNK is critical to the As2O3-induced
apoptosis of ES/PNET and NB cells by treating cells with a
JNK inhibitor. Unexpectedly, combined treatment withSP600125 slightly enhanced As2O3-induced apoptosis.
Although JNK is generally believed to cause As2O3-induced
apoptosis in other cell lines [12,18], there is evidence that the
activation of JNK may be protective in certain cell lines, espe-
cially in cases of oxidative stress-related injuries. The activa-
tion of JNK was found to have protective eﬀects on cardiac
myocytes in a reperfusion injury model and also on the sensory
neurons of diabetic rats under oxidative stress [23,24]. It was
also found that the JNK inhibitor, SP600125, potentiated
As2O3induced activation of p21, and thus caused cell-cycle ar-
rest by inhibiting cyclin-cdk complexes, and cellular cytotoxic-
ity in human epidermoid carcinoma A431 cells. [25].
Diverse apoptotic stimuli, such as UV, irradiation, and
chemicals, may trigger the mitochondrial apoptotic pathway,
which is characterized by the generation of ROS, including
O2 (superoxide radical), H2O2 (hydrogen peroxide), OH (hy-
droxyl free radical) and 1O2 (singlet oxygen) [9]. ROS damage
biological macromolecules and kills cells by oxidizing of lipids
in mitochondrial membranes and the subsequent release of
cytochrome c. Cytochrome c binds to apoptotic protease acti-
vating factor (Apaf-1), recruits initiator caspase 9, which acti-
vates caspase 3. Caspase 3 then cleaves DNA repair enzyme
PARP [poly (ADP-ribose) polymerase] and DNA into nucleo-
somal fragments [15,18,19]. Moreover, intracellular GSH is a
major antioxidant and protects cells from As2O3-induced
ROS generation, and H2O2 is detoxiﬁed by GSH peroxidase
(which requires GSH as a substrate), or by catalase [9,14].
The inverse correlation between As2O3-induced H2O2 genera-
tion and intracellular GSH content demonstrates that the cyto-
toxicity of As2O3 is largely dependent on the generation of
ROS. The present study also shows that ROS seem to play a
key role in the As2O3-induced apoptosis of the cell lines tested,
and that pre-treatment with the antioxidant NAC signiﬁcantly
blocks As2O3-induced cell death and the activations of JNK
and caspase 3.
FGF2 is a major determinant of neural crest cell fate, and
plays a critical role in the diﬀerentiation of neural crest and
some NB cells [26]. FGF2 induces cell death of ES/PNET cells
[15], which is in stark contrast with the neuroprotective role of
FGF2 after ischemic, metabolic or traumatic brain injury [27].
Interestingly, FGF2 can induce the neuronal diﬀerentiation
and apoptosis of PNET cells [28]. In the present study,
FGF2 was found to clearly enhance As2O3-induced apoptosis
in JK-GMS cells.
In summary, the present study describes the biological eﬀects
of As2O3 in ES/PNET cells for the ﬁrst time. As2O3 was found
to diﬀerentially aﬀect the biology of both ES/PNET and NB
cells by inducing cell diﬀerentiation and/or apoptosis depend-
ing on its concentration. Recently, Ryu et al. reported that
As2O3 is well tolerated at concentrations of less than 3 lM
by normal lymphocytes, but it inhibits proliferation and/or in-
duces the apoptosis of SH-SY5Y and SK-N-AS NB cells [29].
Our results strongly suggest that As2O3 can be used as an eﬀec-
tive therapeutic tool for the treatment of neural crest-derived
and childhood solid tumors, either independently or in con-
junction with other biological response modiﬁers like growth
factors.Acknowledgments: This work was supported in part by Grant No.
R01-2001-000-00128-0 from the Korea Science & Engineering Founda-
tion and in part by the BK21 Program for Medicine, Dentistry and
Pharmacy, 2003.
H.S. Jung et al. / FEBS Letters 580 (2006) 4969–4975 4975References
[1] Akao, Y., Yamada, H. and Nakagawa, Y. (2000) Arsenic-induced
apoptosis in malignant cells in vitro. Leuk. Lymphoma 37, 53–63.
[2] Wang, Z.Y. (2001) Arsenic compounds as anticancer agents.
Cancer Chemother. Pharmacol. 48 (Suppl. 1), S72–S76.
[3] Hussein, M.A. (2001) Arsenic trioxide: a new immunomodulatory
agent in the management of multiple myeloma. Med. Oncol. 18,
239–242.
[4] Miller Jr., W.H. (2002) Molecular targets of arsenic trioxide in
malignant cells. Oncologist 7 (Suppl. 1), 14–19.
[5] Miller Jr., W.H., Schipper, H.M., Lee, J.S., Singer, J. and
Waxman, S. (2002) Mechanisms of action of arsenic trioxide.
Cancer Res. 62, 3893–3903.
[6] Zhang, T.D., Chen, G.Q., Wang, Z.G., Wang, Z.Y., Chen, S.J.
and Chen, Z. (2001) Arsenic trioxide, a therapeutic agent for
APL. Oncogene 20, 7146–7153.
[7] Wang, Z.G., Rivi, R., Delva, L., Konig, A., Scheinberg, D.A.,
Gambacorti-Passerini, C., Gabrilove, J.L., Warrell Jr., R.P. and
Pandolﬁ, P.P. (1998) Arsenic trioxide and melarsoprol induce
programmed cell death in myeloid leukemia cell lines and function
in a PML and PML RARalpha independent manner. Blood 92,
1497–1504.
[8] Dai, J., Weinberg, R.S., Waxman, S. and Jing, Y. (1999)
Malignant cells can be sensitized to undergo growth inhibition
and apoptosis by arsenic trioxide through modulation of the
glutathione redox system. Blood 93, 268–277.
[9] Akao, Y., Nakagawa, Y. and Akiyama, K. (1999) Arsenic
trioxide induces apoptosis in neuroblastoma cell lines through
the activation of caspase 3 in vitro. FEBS Lett. 455, 59–62.
[10] Ora, I., Bondesson, L., Jonsson, C., Ljungberg, J., Porn-Ares, I.,
Garwicz, S. and Pahlman, S. (2000) Arsenic trioxide inhibits
neuroblastoma growth in vivo and promotes apoptotic cell death
in vitro. Biochem. Biophys. Res. Commun. 277, 179–185.
[11] Chen, Y.C., Lin-Shiau, S.Y. and Lin, J.K. (1998) Involvement of
reactive oxygen species and caspase 3 activation in arsenite-
induced apoptosis. J. Cell Physiol. 177, 324–333.
[12] Akao, Y., Mizoguchi, H., Kojima, S., Naoe, T., Ohishi, N. and
Yagi, K. (1998) Arsenic induces apoptosis in B-cell leukaemic cell
lines in vitro: activation of caspases and down regulation of Bcl-2
protein. Br. J. Haematol. 102, 1055–1060.
[13] Woo, S.H., Park, I.C., Park, M.J., Lee, H.C., Lee, S.J., Chun,
Y.J., Lee, S.H., Hong, S.I. and Rhee, C.H. (2002) Arsenic trioxide
induces apoptosis through a reactive oxygen species dependent
pathway and loss of mitochondrial membrane potential in HeLa
cells. Int. J. Oncol. 21, 57–63.
[14] Jing, Y., Dai, J., Chalmers-Redman, R.M., Tatton, W.G. and
Waxman, S. (1999) Arsenic trioxide selectively induces acute
promyelocytic leukemia cell apoptosis via a hydrogen peroxide-
dependent pathway. Blood 94, 2102–2111.
[15] Sturla, L.M., Westwood, G., Selby, P.J., Lewis, I.J. and Burchill,
S.A. (2000) Induction of cell death by basic ﬁbroblast growth
factor in Ewing’s sarcoma. Cancer Res. 60, 6160–6170.
[16] Joza, N., Susin, S.A., Daugas, E., Stanford, W.L., Cho, S.K., Li,
C.Y., Sasaki, T., Elia, A.J., Cheng, H.Y., Ravagnan, L., Ferri,
K.F., Zamzami, N., Wakeham, A., Hakem, R., Yoshida, H.,Kong, J.M., Mak, T.W., Zuniga-Pﬂucker, J.C., Kroemer, G. and
Penninger, J.M. (2001) Essential role of the mitochondrial
apoptosis-inducing factor in programmed cell death. Nature
410, 549–554.
[17] Gupta, S. (2003) Molecular signaling in death receptor and
mitochondrial pathways of apoptosis (Review). Int. J. Oncol. 22,
15–20.
[18] Davison, K., Mann, K.K., Waxman, S. and Miller, W.H. (2004)
JNK activation is a mediator of arsenic trioxide-induced apop-
tosis in acute promyelocytic leukemia cells. Blood 103, 3496–
3502.
[19] Maeda, H., Hori, S., Nishitoh, H., Ichijo, H., Ogawa, O., Kakehi,
Y. and Kakizuka, A. (2001) Tumor growth inhibition by arsenic
trioxide (As2O3) in the orthotopic metastasis model of androgen-
independent prostate cancer. Cancer Res. 61, 5432–5440.
[20] Seo, S.R., Chong, S.A., Lee, S.I., Sung, J.Y., Ahn, Y.S., Chung,
K.C. and Seo, J.T. (2001) Zn2+-induced ERK activation mediated
by reactive oxygen species causes cell death in diﬀerentiated PC12
cells. J. Neurochem. 78, 600–610.
[21] Kajiguchi, T., Yamamoto, K., Hossain, K., Akhand, A.A.,
Nakashima, I., Naoe, T., Saito, H. and Emi, N. (2003) Sustained
activation of c-jun-terminal kinase (JNK) is closely related to
arsenic trioxide-induced apoptosis in an acute myeloid leukemia
(M2)-derived cell line, NKM-1. Leukemia 17, 2189–2195.
[22] Park, J.W., Choi, Y.J., Jang, M.A., Baek, S.H., Lim, J.H.,
Passaniti, T. and Kwon, T.K. (2001) Arsenic trioxide induces G2/
M growth arrest and apoptosis after caspase-3 activation and bcl-
2 phosphorylation in promonocytic U937 cells. Biochem. Bio-
phys. Res. Commun. 286, 726–734.
[23] Dougherty, C.J., Kubasiak, L.A., Prentice, H., Andreka, P.,
Bishopric, N.H. and Webster, K.A. (2002) Activation of c-Jun N-
terminal kinase promotes survival of cardiac myocytes after
oxidative stress. Biochem. J. 362, 561–571.
[24] Price, S.A., Hounsom, L., Purves-Tyson, T.D., Fernyhough, P.
and Tomlinson, D.R. (2003) Activation of JNK in sensory
neurons protects against sensory neuron cell death in diabetes and
on exposure to glucose/oxidative stress in vitro. Ann. N. Y. Acad.
Sci. 1010, 95–99.
[25] Huang, H.S., Liu, Z.M., Ding, L., Chang, W.C., Hsu, P.Y.,
Wang, S.H., Chi, C.C. and Chuang, C.H. (2005) Opposite eﬀect
of ERK1/2 and JNK on p53-independent p21(WAF1/CIP1)
activation involved in the arsenic trioxide-induced human epider-
moid carcinoma A431 cellular cytotoxicity. J. Biomed. Sci. 11, 1–
13.
[26] Sieber-Blum, M. and Zhang, J.M. (1997) Growth factor action in
neural crest cell diversiﬁcation. J. Anat. 191, 493–499.
[27] Alzheimer, C. and Werner, S. (2002) Fibroblast growth factors
and neuroprotection. Adv. Exp. Med. Biol. 513, 335–351.
[28] Kim, M.S., Kim, C.J., Jung, H.S., Seo, M.R., Juhnn, Y.S., Shin,
H.Y., Ahn, H.S., Thiele, C.J. and Chi, J.G. (2004) Fibroblast
growth factor 2 induces diﬀerentiation and apoptosis of Askin
tumor cells. J. Pathol. 202, 103–112.
[29] Ryu, K.H., Woo, S.Y., Lee, M.Y., Jung, Y.J., Yoo, E.S., Seoh,
J.Y., Kie, J.H., Shin, H.Y. and Ahn, H.S. (2005) Morphological
and biochemical changes induced by arsenic trioxide in neuro-
blastoma cell lines. Pediatr. Hematol. Oncol. 22, 609–621.
